share_log

EF Hutton Reiterates Buy on VolitionRX, Maintains $6 Price Target

Benzinga ·  Mar 16, 2023 11:24

EF Hutton analyst Constantine Davides reiterates VolitionRX (AMEX:VNRX) with a Buy and maintains $6 price target.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment